BACKGROUND
The fundamental principle of oncologic surgery is the complete resection of malignant cells. However, small tumors are often difficult to find during surgery using conventional techniques. Our objectives were to determine if optical imaging, using a contrast agent already approved for other indications, could improve hepatic metastasectomy with curative intent, to optimize dose and timing, and to determine the mechanism of contrast agent accumulation.
METHODS
We exploited the high tissue penetration of near-infrared (NIR) light using the FLARE™ image-guided surgery system and the NIR fluorophore indocyanine green (ICG) in a clinical trial of 40 patients undergoing hepatic resection for colorectal cancer metastases.
RESULTS
A total of 71 superficially located (< 6.2 mm beneath the liver capsule) colorectal liver metastases were identified and resected using NIR fluorescence imaging. Median tumor-to-liver ratio (TLR) was 7.0 (range 1.9–18.7) and no significant differences between time-points or doses were found. ICG fluorescence was seen as a rim around the tumor, which we show to be entrapment around CK7-positive hepatocytes compressed by the tumor. Importantly, in 5 of 40 patients (12.5%, 95% CI: 5.0–26.6), additional small and superficially located lesions were detected using NIR fluorescence, and were otherwise undetectable by preoperative computed tomography (CT), intraoperative ultrasound (IOUS), visual inspection, and palpation.
CONCLUSION
We conclude that NIR fluorescence imaging, even when utilizing a non-targeted, clinically available NIR fluorophore, is complementary to conventional imaging and able to identify missed lesions by other modalities.